We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$46.3B
1-Year Est. Return
43.9%
This Fund
S&P 500
This Quarter
Est. Return
-13.93%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+647.83%
AUM
$20B
AUM Growth
-$5.25B
(-21%)
Cap. Flow
-$1.13B
Cap. Flow
% of AUM
-5.62%
Top 10 Holdings %
Top 10 Hldgs %
21.83%
Holding
1,650
New
389
Increased
426
Reduced
533
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$109M |
| 2 |
AbbVie
ABBV
|
+$68.7M |
| 3 |
Oracle
ORCL
|
+$63.5M |
| 4 |
Coca-Cola
KO
|
+$54.4M |
| 5 |
Abbott
ABT
|
+$52.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$112M |
| 2 |
Apple
AAPL
|
+$97.1M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$87.3M |
| 4 |
NVIDIA
NVDA
|
+$66.6M |
| 5 |
Microsoft
MSFT
|
+$63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 21.45% |
| 3 | Financials | 13.29% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Consumer Staples | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Targa Resources
TRGP
$61.1B
| $297K | ﹤0.01% |
+4,983
| New | +$358K |
|
852
Neurocrine Biosciences
NBIX
$15.2B
| $295K | ﹤0.01% |
3,024
+185
| +7% | +$17.1K |
|
853
Insight Enterprises
NSIT
$4.85B
| $295K | ﹤0.01% |
3,416
-2,550
| -43% | -$249K |
|
854
Dorman Products
DORM
$3.71B
| $292K | ﹤0.01% |
2,659
+917
| +53% | +$90.8K |
|
855
Toll Brothers
TOL
$12.2B
| $289K | ﹤0.01% |
6,474
+972
| +18% | +$45.5K |
|
|
PRFT
856
DELISTED
Perficient Inc
PRFT
| $289K | ﹤0.01% |
3,151
-3,555
| -53% | -$354K |
|
857
Clarivate
CLVT
$1.2B
| $286K | ﹤0.01% |
20,608
-6,257
| -23% | -$93.6K |
|
858
Comfort Systems
FIX
$55.9B
| $284K | ﹤0.01% |
3,416
-1,882
| -36% | -$162K |
|
859
UMB Financial
UMBF
$10.2B
| $284K | ﹤0.01% |
3,295
-9,897
| -75% | -$897K |
|
860
CVB Financial
CVBF
$4B
| $281K | ﹤0.01% |
+11,330
| New | +$271K |
|
861
Cleveland-Cliffs
CLF
$6.93B
| $280K | ﹤0.01% |
+18,200
| New | +$435K |
|
|
SAFE
862
DELISTED
Safehold Inc.
SAFE
| $280K | ﹤0.01% |
7,917
+1,217
| +18% | +$52.9K |
|
863
Community Bank
CBU
$3.3B
| $278K | ﹤0.01% |
+4,401
| New | +$288K |
|
864
Aecom
ACM
$8.08B
| $277K | ﹤0.01% |
4,244
+2,538
| +149% | +$177K |
|
865
Academy Sports + Outdoors
ASO
$3.1B
| $277K | ﹤0.01% |
+7,803
| New | +$286K |
|
866
Rivian
RIVN
$22.1B
| $277K | ﹤0.01% |
10,762
| – | – |
|
|
CHX
867
DELISTED
ChampionX
CHX
| $276K | ﹤0.01% |
13,903
| – | – |
|
868
Dillards
DDS
$10.1B
| $276K | ﹤0.01% |
1,253
-2,742
| -69% | -$791K |
|
869
Simply Good Foods
SMPL
$901M
| $276K | ﹤0.01% |
7,295
+1,714
| +31% | +$67.9K |
|
870
Piper Sandler
PIPR
$5.04B
| $275K | ﹤0.01% |
9,704
-5,388
| -36% | -$163K |
|
871
RingCentral
RNG
$6.14B
| $275K | ﹤0.01% |
5,265
-160
| -3% | -$12.1K |
|
872
H.B. Fuller
FUL
$2.73B
| $273K | ﹤0.01% |
+4,533
| New | +$304K |
|
873
Prestige Consumer Healthcare
PBH
$2.22B
| $272K | ﹤0.01% |
4,629
-2,356
| -34% | -$130K |
|
874
Avista
AVA
$3.08B
| $271K | ﹤0.01% |
+6,235
| New | +$268K |
|
875
Matsons
MATX
$7.05B
| $271K | ﹤0.01% |
3,713
+664
| +22% | +$57.1K |
|
Similar funds
EP
VCMC
SCP
KBC Group's Q2 2022 Portfolio in Review
As of Q2 2022, KBC Group held 1,650 positions worth $20B, down 21% from $25.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
KBC Group withdrew a net $1.13B in Q2 2022, closing 104 positions and reducing 533 holdings. Its most notable exit was Cerner Corp, an estimated $17.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, KBC Group opened a new position in AstraZeneca worth $1.34M.
- KBC Group's largest Q2 2022 buy was AstraZeneca: 10,181 shares worth $1.34M.
- KBC Group added most to Merck in Q2 2022, an estimated $109M increase.
- KBC Group's biggest Q2 2022 reduction was Amazon, cutting an estimated $112M.
- KBC Group fully exited Cerner Corp in Q2 2022, selling an estimated $17.5M.
- KBC Group's ten largest holdings make up 22% of its $20B portfolio in Q2 2022.
- KBC Group opened 389 new positions and closed 104 in Q2 2022.
- KBC Group's portfolio value fell 21% quarter-over-quarter to $20B.
Based on KBC Group's 13F filing for Q2 2022, filed 26 Jul 2022.